AxoGen (AXGN)

Add to Watchlists
Create an Alert
2.88 +0.02  +0.70% NASDAQ Apr 17, 8:00PM BATS Real time Currency in USD
View Full Chart
AXGN Price Chart
View All Performance Charts

AXGN Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). AxoGen is down 40.98% over the last year vs S&P 500 Total Return up 23.54%, Align Technology up 73.49%, and Abiomed up 38.90%.

Get Quote for

Portfolio Strategies Featuring AXGN

Did AxoGen make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

AXGN Profile

  • Sector: Healthcare
  • Industry: Medical Devices
  • Headquarters Country: United States
  • Headquarters State/Province: Florida
  • Incorporation Country: United States
  • Incorporation State/Province: Minnesota
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Electromedical and Electrotherapeutic Apparatus Manufacturing
  • NAICS Code: 334510
  • NAICS Industry: Navigational, Measuring, Electromedical, and Control Instruments Manufacturing
  • NAICS Industry Code: 3345
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 33

AxoGen, Inc. is a regenerative medicine company with a portfolio of proprietary products and technologies for peripheral nerve reconstruction and regeneration.

Recent Quotes

Symbol Price Chg Chg % Market Cap
AXGN 2.88 +0.02 +0.70% 49.94M
Create Watchlist from Quotes

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

Get Started Now

Upgrade to {{}}. Start Your YCharts Membership. Start your {{}} Membership


{{ ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{}} Member? Sign in here.